Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The high incidence of restenosis after angioplasty has been the leading reason for the recurrence of coronary heart disease, substantially increasing the mortality risk for patients. However, current anti-stenosis drug-eluting stents face challenges due to their limited functions and long-term safety concerns, significantly compromising their therapeutic effect. Herein, a stent-free anti-stenosis drug coating (denoted as Cur-NO-Gel) based on a peptide hydrogel is proposed. This hydrogel is formed by assembling a nitric oxide (NO) donor-peptide conjugate as a hydrogelator and encapsulating curcumin (Cur) during the assembly process. Cur-NO-Gel has the capability to release NO upon β-galactosidase stimulation and gradually release Cur through hydrogel hydrolysis. The in vitro experiments confirmed that Cur-NO-Gel protects vascular endothelial cells against oxidative stress injury, inhibits cellular activation of vascular smooth muscle cells, and suppresses adventitial fibroblasts. Moreover, periadventitial administration of Cur-NO-Gel in the angioplasty model demonstrate its ability to inhibit vascular stenosis by promoting reendothelialization, suppressing neointima hyperplasia, and preventing constrictive remodeling. Therefore, the study provides proof of concept for designing a new generation of clinical drugs in angioplasty.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022711 | PMC |
| http://dx.doi.org/10.1002/advs.202307063 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Catch Up with the Latest Trend in Vascular Access Intervention.
Interv Radiol (Higashimatsuyama)
August 2025
Department of Diagnostic and Interventional Radiology, Nara Medical University, Japan.
Vascular access dysfunction remains a significant challenge in hemodialysis patients, primarily caused by stenosis and occlusion in arteriovenous fistulas and grafts. Recent advancements in percutaneous transluminal angioplasty have introduced innovative tools such as drug-coated balloons and stent grafts. Drug-coated balloons enhance patency by reducing neointimal hyperplasia through localized drug delivery, with superior outcomes demonstrated in randomized controlled trials.
View Article and Find Full Text PDFObjectives: The purpose of this paper was to compare the efficacy of covered stents (CSs) and bare metal stents (BMSs) in treating all types of aortoiliac occlusive disease (AIOD) and subsequently to analyze the risk factors associated with restenosis, limb salvage, and patency.
Methods: This prospective cohort study included consecutive patients with AIOD who underwent aortoiliac angioplasty, and two groups of patients were evaluated: patients with AIOD submitted to endovascular treatment with the use of covered stents and bare metal stents. Patients with critical limb ischemia or incapacitating claudication who underwent aortoiliac angioplasty during the index period were eligible for the study.
Restenosis After Pulmonary Vein Stenting Following Pulmonary Vein Isolation With Nonobstructive General Angioscopy.
JACC Case Rep
September 2025
Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
A 33-year-old male developed pulmonary vein (PV) stenosis 3 months after PV isolation for atrial fibrillation. Stents were implanted in the left superior and inferior PVs, but 2 years later, in-stent restenosis occurred. Intravascular ultrasound and nonobstructive general angioscopy (NOGA) revealed severe ostial stenosis and neointimal hyperplasia.
View Article and Find Full Text PDFProposal of Platelet Anti-aggregation in Transplant Renal Artery Stenosis.
Cureus
August 2025
Medical Research Unit in Nephrological Diseases, Hospital de Especialidades Centro Medico Nacional (CMN) Siglo XXI, Mexico City, MEX.
Introduction Kidney transplant (KT) offers the best renal replacement therapy (RRT), not without being exempt from medical-surgical complications, highlighting those that impact graft function with elevated serum creatinine compounds, such as transplant renal artery stenosis (TRAS), and this study, in turn, has presented some gaps in knowledge, such as anti-aggregation therapy, essentially after the interventionist handling activity. The objective of this document is to propose a platelet anti-aggregation scheme and show the behavior of a series of cases, with a review of the literature. Materials and methods This is a case report of patients with TRAS for five years and six months; patients with a clinical imaging diagnosis of TRAS were included, who were managed with intervention and follow-up.
View Article and Find Full Text PDFComparison of the efficacy of intravascular lithotripsy and rotational atherectomy as adjunctive therapy before drug-eluting stent implantation in calcified coronary lesions (CCS- Coronary Calcification Study).
BMC Cardiovasc Disord
September 2025
Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
Background: This prospective randomized study compares the efficacy of novel intravascular lithotripsy (IVL) to the standard preparation of calcified coronary lesions based on rotational atherectomy (RA).
Methods: A total of 50 patients with 52 calcified lesions were enrolled in the study and randomized 1:1 to be treated with IVL or RA followed by drug-eluting stent (DES) implantation. The procedural success was chosen as a primary endpoint and the 12-month late lumen loss (LLL) as measured by quantitative coronarography, the incidence of binary in-stent restenosis (ISR), 12-month major adverse cardiac events (MACE) and target lesion failure (TLF) served as secondary angiographic and clinical endpoints.